Karen L. Keeperman

Statistics

Publications

Citations

231

H-Index

Active since

2023

Affiliations

Yale University(Current)

Moffitt Cancer Center

Bristol-Myers Squibb (United States)

Yale Cancer Center

The University of Texas MD Anderson Cancer Center

Karen L. Keeperman is an author at Yale University specializing in hematology, myelodysplastic syndrome treatment, and myelodysplastic syndrome therapy.

Publications per year

2023–2024

Publications

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Uwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini et al. · The Lancet · 2023 · 164 citations · Full text

Medicine, Hematology, Pharmacology +14

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial

Matteo Della Porta, Guillermo Garcia‐Manero, Valeria Santini et al. · The Lancet Haematology · 2024 · 48 citations

Medicine, Hematology, Pharmacotherapy +11

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

Uwe Platzbecker, Valeria Santini, Rami S. Komrokji et al. · Leukemia · 2023 · 19 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

1–3 of 3